Agilent Technologies Inc faces a challenging market with a 6-7% revenue decline in the latest quarter. Despite market headwinds, Agilent's CrossLab segment shows resilience with a 4-5% revenue ...

2.2 Headspace gas chromatography-ion mobility spectrometry (HS-GC-IMS) analysis The volatile organic compounds (VOCs) in Hulatang samples were analyzed using the GC-IMS method composed of Agilent 490 ...

Agilent Technologies focuses on growing biopharma, PFAS testing, and advanced materials for semiconductors. Recent acquisitions and divestitures show mixed results, with potential for ...

Aug 21 (Reuters) - Agilent Technologies (A.N), opens new tab on Wednesday beat Wall Street estimates for third-quarter profit and revenue, banking on strong demand for its medical tools and ...

Revenue of $1.58 billion, down 5.6% reported and 4.4% core (1) from the third quarter of 2023. GAAP net income of $282 million; earnings per share (EPS) of $0.97, up 155% from the third quarter of ...